Vincent Cottin

Research interests

Publications

• Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

  Nature Reviews Rheumatology · 2023 · https://doi.org/10.1038/s41584-023-00958-w

• Progressive pulmonary fibrosis: an expert group consensus statement

  European Respiratory Journal · 2022 · https://doi.org/10.1183/13993003.03187-2021

• Spectrum of Fibrotic Lung Diseases

  New England Journal of Medicine · 2020 · 10.1056/nejmra2005230

• Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

  The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30036-9

• Pulmonary alveolar proteinosis

  Nature Reviews Disease Primers · 2019 · https://doi.org/10.1038/s41572-019-0066-3

• Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

  The Lancet Respiratory Medicine · 2019 · https://doi.org/10.1016/s2213-2600(19)30250-4

• Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

  New England Journal of Medicine · 2019 · 10.1056/nejmoa1908681

• Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

  The Lancet Respiratory Medicine · 2019 · 10.1016/s2213-2600(19)30341-8

• Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management

  Current Medical Research and Opinion · 2019 · https://doi.org/10.1080/03007995.2019.1647040

• Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases

  European Respiratory Review · 2018 · https://doi.org/10.1183/16000617.0076-2018

• MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

  New England Journal of Medicine · 2018 · 10.1056/nejmoa1801562

• Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

  American Journal of Respiratory and Critical Care Medicine · 2018 · 10.1164/rccm.201807-1255st

• Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

  European Respiratory Journal · 2017 · 10.1183/13993003.00889-2017

• Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management

  American Journal of Respiratory and Critical Care Medicine · 2016 · 10.1164/rccm.201607-1384st

• Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial

  The Lancet Respiratory Medicine · 2016 · https://doi.org/10.1016/s2213-2600(16)30421-0

• Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

  American Journal of Respiratory and Critical Care Medicine · 2016 · 10.1164/rccm.201604-0801ci

• Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials

  Respiratory Medicine · 2016 · 10.1016/j.rmed.2016.02.001

• Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

  European Journal of Internal Medicine · 2015 · https://doi.org/10.1016/j.ejim.2015.04.022

• An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

  European Respiratory Journal · 2015 · https://doi.org/10.1183/13993003.00150-2015

• Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

  New England Journal of Medicine · 2014 · 10.1056/nejmoa1402584

• Pulmonary Hypertension in Chronic Lung Diseases

  Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2013.10.036

• Pulmonary Hypertension Due to Left Heart Diseases

  Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2013.10.033

• An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

  American Journal of Respiratory and Critical Care Medicine · 2013 · 10.1164/rccm.201308-1483st

• Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

  Pediatric Neurology · 2013 · 10.1016/j.pediatrneurol.2013.08.001

• Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

  Pediatric Neurology · 2013 · 10.1016/j.pediatrneurol.2013.08.002

• The pathogenesis of pulmonary fibrosis: a moving target

  European Respiratory Journal · 2012 · https://doi.org/10.1183/09031936.00073012

• Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

  Circulation · 2010 · 10.1161/circulationaha.109.911818

• Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome

  European Respiratory Journal · 2009 · 10.1183/09031936.00038709

• International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia

  Journal of Medical Genetics · 2009 · 10.1136/jmg.2009.069013

• Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial

  American Journal of Respiratory and Critical Care Medicine · 2008 · 10.1164/rccm.200709-1446oc

• Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity

  European Respiratory Journal · 2005 · 10.1183/09031936.05.00021005

Current projects

No projects listed.